Market closedNon-fractional

Quest Diagnostics/DGX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Quest Diagnostics

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Ticker

DGX

Sector

Healthcare

Trading on

NYSE

Industry

Health Care Providers and Services

Headquarters

Secaucus, United States

Employees

44,000

DGX Metrics

BasicAdvanced
$16B
Market cap
19.83
P/E ratio
$7.43
EPS
0.89
Beta
$2.88
Dividend rate
1.95%
Dividend yield
$16B
0.89
$2.88
0.97
0.782
65.582
81.76
37.71%
7.76%
6.20%
14.15%
19.829
1.773
2.54
-6.32
17.388
1.95%
-3.29%
9.35%
-3.50%
-17.39%
7.78%

What the Analysts think about DGX

Analyst Ratings

Majority rating from 18 analysts.
Hold

DGX Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
8.19% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$2.4B
3.41%
Net income
$194M
1.04%
Profit margin
8.19%
-2.38%

DGX Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 9.95%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$2.30
$2.22
$2.15
$2.04
-
Expected
$2.27
$2.19
$2.11
$1.86
$2.34
Surprise
1.48%
1.41%
1.70%
9.95%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Quest Diagnostics stock?

Quest Diagnostics (DGX) has a market cap of $16B as of July 23, 2024.

What is the P/E ratio for Quest Diagnostics stock?

The price to earnings (P/E) ratio for Quest Diagnostics (DGX) stock is 19.83 as of July 23, 2024.

Does Quest Diagnostics stock pay dividends?

Yes, the Quest Diagnostics (DGX) stock pays dividends to shareholders. As of July 23, 2024, the dividend rate is $2.88 and the yield is 1.95%. Quest Diagnostics has a payout ratio of 37.71% on a trailing twelve-month basis.

When is the next Quest Diagnostics dividend payment date?

The next Quest Diagnostics (DGX) dividend payment date is unconfirmed.

What is the beta indicator for Quest Diagnostics?

Quest Diagnostics (DGX) has a beta rating of 0.89. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Quest Diagnostics stock

Buy or sell Quest Diagnostics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing